An engineered bispecific human monoclonal antibody against SARS-CoV-2

Zhaohui Li; Shihua Li; Gen Zhang; Weiyu Peng; Zhen Chang; Xue Zhang; Zheng Fan; Yan Chai; Feiran Wang; Xin Zhao; Dedong Li; Rong Zhang; Zhanlong He; Weiwei Zou; Ke Xu; Wenwen Lei; Peipei Liu; Junfeng Hao; Jingjing Zhang; Litao Sun; Guizhen Wu; Shuguang Tan; George F. Gao; Feng Gao; Yan Wu

doi:10.1038/s41590-022-01138-w

An engineered bispecific human monoclonal antibody against SARS-CoV-2

Zhaohui Li(Chinese Academy of Sciences), Shihua Li(Chinese Academy of Sciences), Gen Zhang(Chinese Academy of Sciences), Weiyu Peng(Chinese Academy of Sciences), Zhen Chang(Capital Medical University), Xue Zhang(Capital Medical University), Zheng Fan(Chinese Academy of Sciences), Yan Chai(Chinese Academy of Sciences), Feiran Wang(University of Science and Technology of China), Xin Zhao(Chinese Academy of Sciences), Dedong Li(Chinese Academy of Sciences), Rong Zhang(Guangxi University), Zhanlong He(Chinese Academy of Medical Sciences & Peking Union Medical College), Weiwei Zou(Capital Medical University), Ke Xu(National Institute for Viral Disease Control and Prevention), Wenwen Lei(National Institute for Viral Disease Control and Prevention), Peipei Liu(National Institute for Viral Disease Control and Prevention), Junfeng Hao(Chinese Academy of Sciences), Jingjing Zhang(Sun Yat-sen University), Litao Sun(Sun Yat-sen University), Guizhen Wu(National Institute for Viral Disease Control and Prevention), Shuguang Tan(Chinese Academy of Sciences), George F. Gao(Chinese Academy of Sciences), Feng Gao(Chinese Academy of Sciences), Yan Wu(Capital Medical University)

Nature Immunology

February 28, 2022

10.1038/s41590-022-01138-w

Cited by 83Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis